id	sid	tid	token	lemma	pos
cord-308212-l8flyso7	1	1	key	key	NNP
cord-308212-l8flyso7	1	2	:	:	:
cord-308212-l8flyso7	1	3	cord-308212-l8flyso7	cord-308212-l8flyso7	ADD
cord-308212-l8flyso7	2	1	authors	author	NNS
cord-308212-l8flyso7	2	2	:	:	:
cord-308212-l8flyso7	2	3	Kong	Kong	NNP
cord-308212-l8flyso7	2	4	,	,	,
cord-308212-l8flyso7	2	5	Ha	Ha	NNP
cord-308212-l8flyso7	2	6	Eun	Eun	NNP
cord-308212-l8flyso7	2	7	;	;	:
cord-308212-l8flyso7	2	8	Grant	Grant	NNP
cord-308212-l8flyso7	2	9	-	-	HYPH
cord-308212-l8flyso7	2	10	Kels	Kels	NNP
cord-308212-l8flyso7	2	11	,	,	,
cord-308212-l8flyso7	2	12	Jane	Jane	NNP
cord-308212-l8flyso7	2	13	M.	M.	NNP
cord-308212-l8flyso7	2	14	;	;	:
cord-308212-l8flyso7	2	15	Stoff	Stoff	NNP
cord-308212-l8flyso7	2	16	,	,	,
cord-308212-l8flyso7	2	17	Benjamin	Benjamin	NNP
cord-308212-l8flyso7	2	18	K.	K.	NNP
cord-308212-l8flyso7	2	19	title	title	NN
cord-308212-l8flyso7	2	20	:	:	:
cord-308212-l8flyso7	3	1	Applying	apply	VBG
cord-308212-l8flyso7	3	2	the	the	DT
cord-308212-l8flyso7	3	3	ethical	ethical	JJ
cord-308212-l8flyso7	3	4	principles	principle	NNS
cord-308212-l8flyso7	3	5	of	of	IN
cord-308212-l8flyso7	3	6	resource	resource	NN
cord-308212-l8flyso7	3	7	allocation	allocation	NN
cord-308212-l8flyso7	3	8	to	to	IN
cord-308212-l8flyso7	3	9	drugs	drug	NNS
cord-308212-l8flyso7	3	10	in	in	IN
cord-308212-l8flyso7	3	11	limited	limited	JJ
cord-308212-l8flyso7	3	12	supply	supply	NN
cord-308212-l8flyso7	3	13	during	during	IN
cord-308212-l8flyso7	3	14	a	a	DT
cord-308212-l8flyso7	3	15	public	public	JJ
cord-308212-l8flyso7	3	16	health	health	NN
cord-308212-l8flyso7	3	17	crisis	crisis	NN
cord-308212-l8flyso7	3	18	date	date	NN
cord-308212-l8flyso7	3	19	:	:	:
cord-308212-l8flyso7	3	20	2020	2020	CD
cord-308212-l8flyso7	3	21	-	-	HYPH
cord-308212-l8flyso7	3	22	04	04	CD
cord-308212-l8flyso7	3	23	-	-	SYM
cord-308212-l8flyso7	3	24	21	21	CD
cord-308212-l8flyso7	3	25	journal	journal	NN
cord-308212-l8flyso7	3	26	:	:	:
cord-308212-l8flyso7	4	1	J	J	NNP
cord-308212-l8flyso7	4	2	Am	be	VBP
cord-308212-l8flyso7	5	1	Acad	Acad	NNP
cord-308212-l8flyso7	5	2	Dermatol	Dermatol	NNP
cord-308212-l8flyso7	5	3	DOI	DOI	NNP
cord-308212-l8flyso7	5	4	:	:	:
cord-308212-l8flyso7	5	5	10.1016/	10.1016/	CD
cord-308212-l8flyso7	6	1	j.jaad.2020.04.078	j.jaad.2020.04.078	NNP
cord-308212-l8flyso7	7	1	sha	sha	NNP
cord-308212-l8flyso7	7	2	:	:	:
cord-308212-l8flyso7	8	1	6aaa3db9f6e7ef3751b4bc9345b12181b0f6f425	6aaa3db9f6e7ef3751b4bc9345b12181b0f6f425	CD
cord-308212-l8flyso7	8	2	doc_id	doc_id	CD
cord-308212-l8flyso7	8	3	:	:	:
cord-308212-l8flyso7	8	4	308212	308212	CD
cord-308212-l8flyso7	8	5	cord_uid	cord_uid	NNS
cord-308212-l8flyso7	8	6	:	:	:
cord-308212-l8flyso7	8	7	l8flyso7	l8flyso7	.
cord-308212-l8flyso7	9	1	nan	nan	NNP
cord-308212-l8flyso7	9	2	Saving	save	VBG
cord-308212-l8flyso7	9	3	the	the	DT
cord-308212-l8flyso7	9	4	most	most	JJS
cord-308212-l8flyso7	9	5	lives	life	NNS
cord-308212-l8flyso7	9	6	/	/	SYM
cord-308212-l8flyso7	9	7	life	life	NN
cord-308212-l8flyso7	9	8	-	-	HYPH
cord-308212-l8flyso7	9	9	years	year	NNS
cord-308212-l8flyso7	9	10	is	be	VBZ
cord-308212-l8flyso7	9	11	the	the	DT
cord-308212-l8flyso7	9	12	highest	high	JJS
cord-308212-l8flyso7	9	13	priority	priority	NN
cord-308212-l8flyso7	9	14	.	.	.
cord-308212-l8flyso7	10	1	Random	random	JJ
cord-308212-l8flyso7	10	2	selection	selection	NN
cord-308212-l8flyso7	10	3	can	can	MD
cord-308212-l8flyso7	10	4	be	be	VB
cord-308212-l8flyso7	10	5	used	use	VBN
cord-308212-l8flyso7	10	6	for	for	IN
cord-308212-l8flyso7	10	7	selecting	select	VBG
cord-308212-l8flyso7	10	8	among	among	IN
cord-308212-l8flyso7	10	9	patients	patient	NNS
cord-308212-l8flyso7	10	10	with	with	IN
cord-308212-l8flyso7	10	11	comparable	comparable	JJ
cord-308212-l8flyso7	10	12	prognoses	prognosis	NNS
cord-308212-l8flyso7	10	13	.	.	.
cord-308212-l8flyso7	11	1	Healthcare	healthcare	NN
cord-308212-l8flyso7	11	2	workers	worker	NNS
cord-308212-l8flyso7	11	3	should	should	MD
cord-308212-l8flyso7	11	4	be	be	VB
cord-308212-l8flyso7	11	5	prioritized	prioritize	VBN
cord-308212-l8flyso7	11	6	.	.	.
cord-308212-l8flyso7	12	1	With	with	IN
cord-308212-l8flyso7	12	2	other	other	JJ
cord-308212-l8flyso7	12	3	factors	factor	NNS
cord-308212-l8flyso7	12	4	equal	equal	JJ
cord-308212-l8flyso7	12	5	,	,	,
cord-308212-l8flyso7	12	6	give	give	VBP
cord-308212-l8flyso7	12	7	priority	priority	NN
cord-308212-l8flyso7	12	8	to	to	IN
cord-308212-l8flyso7	12	9	COVID-19	covid-19	JJ
cord-308212-l8flyso7	12	10	research	research	NN
cord-308212-l8flyso7	12	11	participants	participant	NNS
cord-308212-l8flyso7	12	12	.	.	.
cord-308212-l8flyso7	13	1	aligns	align	VBZ
cord-308212-l8flyso7	13	2	with	with	IN
cord-308212-l8flyso7	13	3	maximizing	maximize	VBG
cord-308212-l8flyso7	13	4	benefits	benefit	NNS
cord-308212-l8flyso7	13	5	e.g.	e.g.	RB
cord-308212-l8flyso7	13	6	saving	save	VBG
cord-308212-l8flyso7	13	7	most	most	JJS
cord-308212-l8flyso7	13	8	years	year	NNS
cord-308212-l8flyso7	13	9	of	of	IN
cord-308212-l8flyso7	13	10	life	life	NN
cord-308212-l8flyso7	13	11	or	or	CC
cord-308212-l8flyso7	13	12	preventing	prevent	VBG
cord-308212-l8flyso7	13	13	further	further	JJ
cord-308212-l8flyso7	13	14	spread	spread	NN
cord-308212-l8flyso7	13	15	of	of	IN
cord-308212-l8flyso7	13	16	virus	virus	NN
cord-308212-l8flyso7	13	17	.	.	.
cord-308212-l8flyso7	14	1	45	45	CD
cord-308212-l8flyso7	15	1	During	during	IN
cord-308212-l8flyso7	15	2	a	a	DT
cord-308212-l8flyso7	15	3	pandemic	pandemic	NN
cord-308212-l8flyso7	15	4	,	,	,
cord-308212-l8flyso7	15	5	priority	priority	NN
cord-308212-l8flyso7	15	6	should	should	MD
cord-308212-l8flyso7	15	7	be	be	VB
cord-308212-l8flyso7	15	8	given	give	VBN
cord-308212-l8flyso7	15	9	to	to	IN
cord-308212-l8flyso7	15	10	those	those	DT
cord-308212-l8flyso7	15	11	whose	whose	WP$
cord-308212-l8flyso7	15	12	survival	survival	NN
cord-308212-l8flyso7	15	13	would	would	MD
cord-308212-l8flyso7	15	14	benefit	benefit	VB
cord-308212-l8flyso7	15	15	most	most	JJS
cord-308212-l8flyso7	15	16	from	from	IN
cord-308212-l8flyso7	15	17	46	46	CD
cord-308212-l8flyso7	15	18	treatment	treatment	NN
cord-308212-l8flyso7	15	19	in	in	IN
cord-308212-l8flyso7	15	20	order	order	NN
cord-308212-l8flyso7	15	21	to	to	TO
cord-308212-l8flyso7	15	22	maximize	maximize	VB
cord-308212-l8flyso7	15	23	benefit	benefit	NN
cord-308212-l8flyso7	15	24	to	to	IN
cord-308212-l8flyso7	15	25	society	society	NN
cord-308212-l8flyso7	15	26	.	.	.
cord-308212-l8flyso7	16	1	Applying	apply	VBG
cord-308212-l8flyso7	16	2	this	this	DT
cord-308212-l8flyso7	16	3	principle	principle	NN
cord-308212-l8flyso7	16	4	to	to	IN
cord-308212-l8flyso7	16	5	antimalarials	antimalarial	NNS
cord-308212-l8flyso7	16	6	,	,	,
cord-308212-l8flyso7	16	7	severe	severe	JJ
cord-308212-l8flyso7	16	8	47	47	CD
cord-308212-l8flyso7	16	9	COVID-19	covid-19	CD
cord-308212-l8flyso7	16	10	patients	patient	NNS
cord-308212-l8flyso7	16	11	as	as	RB
cord-308212-l8flyso7	16	12	well	well	RB
cord-308212-l8flyso7	16	13	as	as	IN
cord-308212-l8flyso7	16	14	patients	patient	NNS
cord-308212-l8flyso7	16	15	with	with	IN
cord-308212-l8flyso7	16	16	malaria	malaria	NN
cord-308212-l8flyso7	16	17	or	or	CC
cord-308212-l8flyso7	16	18	severe	severe	JJ
cord-308212-l8flyso7	16	19	rheumatologic	rheumatologic	JJ
cord-308212-l8flyso7	16	20	disease	disease	NN
cord-308212-l8flyso7	16	21	,	,	,
cord-308212-l8flyso7	16	22	for	for	IN
cord-308212-l8flyso7	16	23	whom	whom	WP
cord-308212-l8flyso7	16	24	48	48	CD
cord-308212-l8flyso7	16	25	other	other	JJ
cord-308212-l8flyso7	16	26	effective	effective	JJ
cord-308212-l8flyso7	16	27	treatments	treatment	NNS
cord-308212-l8flyso7	16	28	are	be	VBP
cord-308212-l8flyso7	16	29	unavailable	unavailable	JJ
cord-308212-l8flyso7	16	30	,	,	,
cord-308212-l8flyso7	16	31	should	should	MD
cord-308212-l8flyso7	16	32	be	be	VB
cord-308212-l8flyso7	16	33	favored	favor	VBN
cord-308212-l8flyso7	16	34	.	.	.
cord-308212-l8flyso7	17	1	If	if	IN
cord-308212-l8flyso7	17	2	dermatology	dermatology	NN
cord-308212-l8flyso7	17	3	patients	patient	NNS
cord-308212-l8flyso7	17	4	eligible	eligible	JJ
cord-308212-l8flyso7	17	5	for	for	IN
cord-308212-l8flyso7	17	6	49	49	CD
cord-308212-l8flyso7	17	7	antimalarials	antimalarial	NNS
cord-308212-l8flyso7	17	8	have	have	VBP
cord-308212-l8flyso7	17	9	other	other	JJ
cord-308212-l8flyso7	17	10	,	,	,
cord-308212-l8flyso7	17	11	comparably	comparably	RB
cord-308212-l8flyso7	17	12	-	-	HYPH
cord-308212-l8flyso7	17	13	effective	effective	JJ
cord-308212-l8flyso7	17	14	treatment	treatment	NN
cord-308212-l8flyso7	17	15	options	option	NNS
cord-308212-l8flyso7	17	16	,	,	,
cord-308212-l8flyso7	17	17	dermatologists	dermatologist	NNS
cord-308212-l8flyso7	17	18	should	should	MD
cord-308212-l8flyso7	17	19	50	50	CD
cord-308212-l8flyso7	17	20	recommend	recommend	VB
cord-308212-l8flyso7	17	21	alternatives	alternative	NNS
cord-308212-l8flyso7	17	22	,	,	,
cord-308212-l8flyso7	17	23	particularly	particularly	RB
cord-308212-l8flyso7	17	24	for	for	IN
cord-308212-l8flyso7	17	25	mild	mild	JJ
cord-308212-l8flyso7	17	26	-	-	HYPH
cord-308212-l8flyso7	17	27	to	to	IN
cord-308212-l8flyso7	17	28	-	-	HYPH
cord-308212-l8flyso7	17	29	moderate	moderate	JJ
cord-308212-l8flyso7	17	30	disease	disease	NN
cord-308212-l8flyso7	17	31	.	.	.
cord-308212-l8flyso7	18	1	Finally	finally	RB
cord-308212-l8flyso7	18	2	,	,	,
cord-308212-l8flyso7	18	3	providers	provider	NNS
cord-308212-l8flyso7	18	4	should	should	MD
cord-308212-l8flyso7	18	5	51	51	CD
cord-308212-l8flyso7	18	6	not	not	RB
cord-308212-l8flyso7	18	7	prescribe	prescribe	VB
cord-308212-l8flyso7	18	8	these	these	DT
cord-308212-l8flyso7	18	9	drugs	drug	NNS
cord-308212-l8flyso7	18	10	to	to	IN
cord-308212-l8flyso7	18	11	the	the	DT
cord-308212-l8flyso7	18	12	"	"	``
cord-308212-l8flyso7	18	13	worried	worried	JJ
cord-308212-l8flyso7	18	14	well	well	RB
cord-308212-l8flyso7	18	15	,	,	,
cord-308212-l8flyso7	18	16	"	"	''
cord-308212-l8flyso7	18	17	who	who	WP
cord-308212-l8flyso7	18	18	may	may	MD
cord-308212-l8flyso7	18	19	be	be	VB
cord-308212-l8flyso7	18	20	hoarding	hoard	VBG
cord-308212-l8flyso7	18	21	medication	medication	NN
cord-308212-l8flyso7	18	22	in	in	IN
cord-308212-l8flyso7	18	23	case	case	NN
cord-308212-l8flyso7	18	24	of	of	IN
cord-308212-l8flyso7	18	25	52	52	CD
cord-308212-l8flyso7	18	26	illness	illness	NN
cord-308212-l8flyso7	18	27	.	.	.
cord-308212-l8flyso7	19	1	Clinicians	clinician	NNS
cord-308212-l8flyso7	19	2	must	must	MD
cord-308212-l8flyso7	19	3	reassess	reassess	VB
cord-308212-l8flyso7	19	4	allocation	allocation	NN
cord-308212-l8flyso7	19	5	strategies	strategy	NNS
cord-308212-l8flyso7	19	6	as	as	IN
cord-308212-l8flyso7	19	7	new	new	JJ
cord-308212-l8flyso7	19	8	data	datum	NNS
cord-308212-l8flyso7	19	9	emerge	emerge	VBP
cord-308212-l8flyso7	19	10	.	.	.
cord-308212-l8flyso7	20	1	The	the	DT
cord-308212-l8flyso7	20	2	efficacy	efficacy	NN
cord-308212-l8flyso7	20	3	of	of	IN
cord-308212-l8flyso7	20	4	55	55	CD
cord-308212-l8flyso7	20	5	antimalarials	antimalarial	NNS
cord-308212-l8flyso7	20	6	for	for	IN
cord-308212-l8flyso7	20	7	COVID-19	COVID-19	NNP
cord-308212-l8flyso7	20	8	should	should	MD
cord-308212-l8flyso7	20	9	be	be	VB
cord-308212-l8flyso7	20	10	assessed	assess	VBN
cord-308212-l8flyso7	20	11	via	via	IN
cord-308212-l8flyso7	20	12	randomized	randomized	JJ
cord-308212-l8flyso7	20	13	clinical	clinical	JJ
cord-308212-l8flyso7	20	14	trials	trial	NNS
cord-308212-l8flyso7	20	15	(	(	-LRB-
cord-308212-l8flyso7	20	16	RCTs	RCTs	NNP
cord-308212-l8flyso7	20	17	)	)	-RRB-
cord-308212-l8flyso7	20	18	,	,	,
cord-308212-l8flyso7	20	19	which	which	WDT
cord-308212-l8flyso7	20	20	are	be	VBP
cord-308212-l8flyso7	20	21	56	56	CD
cord-308212-l8flyso7	20	22	ongoing	ongoing	JJ
cord-308212-l8flyso7	20	23	.	.	.
cord-308212-l8flyso7	21	1	For	for	IN
cord-308212-l8flyso7	21	2	example	example	NN
cord-308212-l8flyso7	21	3	,	,	,
cord-308212-l8flyso7	21	4	a	a	DT
cord-308212-l8flyso7	21	5	small	small	JJ
cord-308212-l8flyso7	21	6	open	open	JJ
cord-308212-l8flyso7	21	7	-	-	HYPH
cord-308212-l8flyso7	21	8	label	label	NN
cord-308212-l8flyso7	21	9	French	french	JJ
cord-308212-l8flyso7	21	10	study	study	NN
cord-308212-l8flyso7	21	11	demonstrated	demonstrate	VBD
cord-308212-l8flyso7	21	12	reduction	reduction	NN
cord-308212-l8flyso7	21	13	in	in	IN
cord-308212-l8flyso7	21	14	viral	viral	JJ
cord-308212-l8flyso7	21	15	load	load	NN
cord-308212-l8flyso7	21	16	,	,	,
cord-308212-l8flyso7	21	17	57	57	CD
cord-308212-l8flyso7	21	18	but	but	CC
cord-308212-l8flyso7	21	19	did	do	VBD
cord-308212-l8flyso7	21	20	not	not	RB
cord-308212-l8flyso7	21	21	assess	assess	VB
cord-308212-l8flyso7	21	22	mortality	mortality	NN
cord-308212-l8flyso7	21	23	or	or	CC
cord-308212-l8flyso7	21	24	morbidity	morbidity	NN
cord-308212-l8flyso7	21	25	1	1	CD
cord-308212-l8flyso7	21	26	.	.	.
cord-308212-l8flyso7	22	1	In	in	IN
cord-308212-l8flyso7	22	2	contrast	contrast	NN
cord-308212-l8flyso7	22	3	,	,	,
cord-308212-l8flyso7	22	4	for	for	IN
cord-308212-l8flyso7	22	5	systemic	systemic	JJ
cord-308212-l8flyso7	22	6	lupus	lupus	NN
cord-308212-l8flyso7	22	7	erythematosus	erythematosus	NN
cord-308212-l8flyso7	22	8	(	(	-LRB-
cord-308212-l8flyso7	22	9	SLE	SLE	NNP
cord-308212-l8flyso7	22	10	)	)	-RRB-
cord-308212-l8flyso7	22	11	58	58	CD
cord-308212-l8flyso7	22	12	patients	patient	NNS
cord-308212-l8flyso7	22	13	,	,	,
cord-308212-l8flyso7	22	14	a	a	DT
cord-308212-l8flyso7	22	15	RCT	RCT	NNP
cord-308212-l8flyso7	22	16	showed	show	VBD
cord-308212-l8flyso7	22	17	that	that	IN
cord-308212-l8flyso7	22	18	discontinuing	discontinue	VBG
cord-308212-l8flyso7	22	19	hydroxychloroquine	hydroxychloroquine	NN
cord-308212-l8flyso7	22	20	leads	lead	VBZ
cord-308212-l8flyso7	22	21	to	to	IN
cord-308212-l8flyso7	22	22	a	a	DT
cord-308212-l8flyso7	22	23	2.5x	2.5x	CD
cord-308212-l8flyso7	22	24	increased	increase	VBN
cord-308212-l8flyso7	22	25	59	59	CD
cord-308212-l8flyso7	22	26	relative	relative	JJ
cord-308212-l8flyso7	22	27	risk	risk	NN
cord-308212-l8flyso7	22	28	of	of	IN
cord-308212-l8flyso7	22	29	clinically	clinically	RB
cord-308212-l8flyso7	22	30	-	-	HYPH
cord-308212-l8flyso7	22	31	relevant	relevant	JJ
cord-308212-l8flyso7	22	32	flares	flare	NNS
cord-308212-l8flyso7	22	33	and	and	CC
cord-308212-l8flyso7	22	34	a	a	DT
cord-308212-l8flyso7	22	35	6x	6x	CD
cord-308212-l8flyso7	22	36	increased	increase	VBN
cord-308212-l8flyso7	22	37	relative	relative	JJ
cord-308212-l8flyso7	22	38	risk	risk	NN
cord-308212-l8flyso7	22	39	of	of	IN
cord-308212-l8flyso7	22	40	severe	severe	JJ
cord-308212-l8flyso7	22	41	exacerbation	exacerbation	NN
cord-308212-l8flyso7	22	42	60	60	CD
cord-308212-l8flyso7	22	43	compared	compare	VBN
cord-308212-l8flyso7	22	44	to	to	IN
cord-308212-l8flyso7	22	45	placebo	placebo	NN
cord-308212-l8flyso7	22	46	4	4	CD
cord-308212-l8flyso7	22	47	.	.	.
cord-308212-l8flyso7	23	1	While	while	IN
cord-308212-l8flyso7	23	2	the	the	DT
cord-308212-l8flyso7	23	3	benefit	benefit	NN
cord-308212-l8flyso7	23	4	of	of	IN
cord-308212-l8flyso7	23	5	antimalarials	antimalarial	NNS
cord-308212-l8flyso7	23	6	to	to	IN
cord-308212-l8flyso7	23	7	COVID-19	covid-19	VB
cord-308212-l8flyso7	23	8	patients	patient	NNS
cord-308212-l8flyso7	23	9	remains	remain	VBZ
cord-308212-l8flyso7	23	10	61	61	CD
cord-308212-l8flyso7	23	11	uncertain	uncertain	JJ
cord-308212-l8flyso7	23	12	,	,	,
cord-308212-l8flyso7	23	13	high	high	JJ
cord-308212-l8flyso7	23	14	-	-	HYPH
cord-308212-l8flyso7	23	15	quality	quality	NN
cord-308212-l8flyso7	23	16	evidence	evidence	NN
cord-308212-l8flyso7	23	17	supports	support	VBZ
cord-308212-l8flyso7	23	18	continuing	continue	VBG
cord-308212-l8flyso7	23	19	treatment	treatment	NN
cord-308212-l8flyso7	23	20	in	in	IN
cord-308212-l8flyso7	23	21	patients	patient	NNS
cord-308212-l8flyso7	23	22	with	with	IN
cord-308212-l8flyso7	23	23	severe	severe	JJ
cord-308212-l8flyso7	23	24	SLE	sle	NN
cord-308212-l8flyso7	23	25	.	.	.
cord-308212-l8flyso7	24	1	62	62	CD
cord-308212-l8flyso7	25	1	What	what	WP
cord-308212-l8flyso7	25	2	is	be	VBZ
cord-308212-l8flyso7	25	3	the	the	DT
cord-308212-l8flyso7	25	4	role	role	NN
cord-308212-l8flyso7	25	5	of	of	IN
cord-308212-l8flyso7	25	6	patient	patient	JJ
cord-308212-l8flyso7	25	7	autonomy	autonomy	NN
cord-308212-l8flyso7	25	8	in	in	IN
cord-308212-l8flyso7	25	9	public	public	JJ
cord-308212-l8flyso7	25	10	health	health	NN
cord-308212-l8flyso7	25	11	emergencies	emergency	NNS
cord-308212-l8flyso7	25	12	?	?	.
cord-308212-l8flyso7	26	1	Under	under	IN
cord-308212-l8flyso7	26	2	normal	normal	JJ
cord-308212-l8flyso7	26	3	63	63	CD
cord-308212-l8flyso7	26	4	circumstances	circumstance	NNS
cord-308212-l8flyso7	26	5	,	,	,
cord-308212-l8flyso7	26	6	if	if	IN
cord-308212-l8flyso7	26	7	a	a	DT
cord-308212-l8flyso7	26	8	reasonable	reasonable	JJ
cord-308212-l8flyso7	26	9	patient	patient	NN
cord-308212-l8flyso7	26	10	prefers	prefer	VBZ
cord-308212-l8flyso7	26	11	antimalarials	antimalarial	NNS
cord-308212-l8flyso7	26	12	for	for	IN
cord-308212-l8flyso7	26	13	skin	skin	NN
cord-308212-l8flyso7	26	14	disease	disease	NN
cord-308212-l8flyso7	26	15	,	,	,
cord-308212-l8flyso7	26	16	and	and	CC
cord-308212-l8flyso7	26	17	the	the	DT
cord-308212-l8flyso7	26	18	treatment	treatment	NN
cord-308212-l8flyso7	26	19	64	64	CD
cord-308212-l8flyso7	26	20	is	be	VBZ
cord-308212-l8flyso7	26	21	indicated	indicate	VBN
cord-308212-l8flyso7	26	22	,	,	,
cord-308212-l8flyso7	26	23	then	then	RB
cord-308212-l8flyso7	26	24	the	the	DT
cord-308212-l8flyso7	26	25	drugs	drug	NNS
cord-308212-l8flyso7	26	26	should	should	MD
cord-308212-l8flyso7	26	27	be	be	VB
cord-308212-l8flyso7	26	28	prescribed	prescribe	VBN
cord-308212-l8flyso7	26	29	.	.	.
cord-308212-l8flyso7	27	1	However	however	RB
cord-308212-l8flyso7	27	2	,	,	,
cord-308212-l8flyso7	27	3	patient	patient	JJ
cord-308212-l8flyso7	27	4	autonomy	autonomy	NN
cord-308212-l8flyso7	27	5	is	be	VBZ
cord-308212-l8flyso7	27	6	diminished	diminish	VBN
cord-308212-l8flyso7	27	7	in	in	IN
cord-308212-l8flyso7	27	8	65	65	CD
cord-308212-l8flyso7	27	9	public	public	JJ
cord-308212-l8flyso7	27	10	health	health	NN
cord-308212-l8flyso7	27	11	emergencies	emergency	NNS
cord-308212-l8flyso7	27	12	,	,	,
cord-308212-l8flyso7	27	13	as	as	IN
cord-308212-l8flyso7	27	14	healthcare	healthcare	NN
cord-308212-l8flyso7	27	15	ethics	ethic	NNS
cord-308212-l8flyso7	27	16	shifts	shift	VBZ
cord-308212-l8flyso7	27	17	priority	priority	NN
cord-308212-l8flyso7	27	18	to	to	IN
cord-308212-l8flyso7	27	19	populations	population	NNS
cord-308212-l8flyso7	27	20	over	over	IN
cord-308212-l8flyso7	27	21	individuals	individual	NNS
cord-308212-l8flyso7	27	22	5	5	CD
cord-308212-l8flyso7	27	23	.	.	.
cord-308212-l8flyso7	28	1	66	66	CD
cord-308212-l8flyso7	29	1	Currently	currently	RB
cord-308212-l8flyso7	29	2	,	,	,
cord-308212-l8flyso7	29	3	many	many	JJ
cord-308212-l8flyso7	29	4	states	state	NNS
cord-308212-l8flyso7	29	5	in	in	IN
cord-308212-l8flyso7	29	6	the	the	DT
cord-308212-l8flyso7	29	7	US	US	NNP
cord-308212-l8flyso7	29	8	have	have	VBP
cord-308212-l8flyso7	29	9	limited	limit	VBN
cord-308212-l8flyso7	29	10	prescribing	prescribing	NN
cord-308212-l8flyso7	29	11	of	of	IN
cord-308212-l8flyso7	29	12	hydroxychloroquine	hydroxychloroquine	NN
cord-308212-l8flyso7	29	13	,	,	,
cord-308212-l8flyso7	29	14	but	but	CC
cord-308212-l8flyso7	29	15	these	these	DT
cord-308212-l8flyso7	29	16	67	67	CD
cord-308212-l8flyso7	29	17	limitations	limitation	NNS
cord-308212-l8flyso7	29	18	generally	generally	RB
cord-308212-l8flyso7	29	19	do	do	VBP
cord-308212-l8flyso7	29	20	n't	not	RB
cord-308212-l8flyso7	29	21	apply	apply	VB
cord-308212-l8flyso7	29	22	to	to	IN
cord-308212-l8flyso7	29	23	patients	patient	NNS
cord-308212-l8flyso7	29	24	on	on	IN
cord-308212-l8flyso7	29	25	drug	drug	NN
cord-308212-l8flyso7	29	26	for	for	IN
cord-308212-l8flyso7	29	27	approved	approve	VBN
cord-308212-l8flyso7	29	28	indications	indication	NNS
cord-308212-l8flyso7	29	29	6	6	CD
cord-308212-l8flyso7	29	30	.	.	.
cord-308212-l8flyso7	30	1	In	in	IN
cord-308212-l8flyso7	30	2	applying	apply	VBG
cord-308212-l8flyso7	30	3	the	the	DT
cord-308212-l8flyso7	30	4	68	68	CD
cord-308212-l8flyso7	30	5	ethical	ethical	JJ
cord-308212-l8flyso7	30	6	principles	principle	NNS
cord-308212-l8flyso7	30	7	of	of	IN
cord-308212-l8flyso7	30	8	resource	resource	NN
cord-308212-l8flyso7	30	9	allocation	allocation	NN
cord-308212-l8flyso7	30	10	(	(	-LRB-
cord-308212-l8flyso7	30	11	Table	table	NN
cord-308212-l8flyso7	30	12	I	i	CD
cord-308212-l8flyso7	30	13	)	)	-RRB-
cord-308212-l8flyso7	30	14	Table	table	NN
cord-308212-l8flyso7	30	15	1	1	CD
cord-308212-l8flyso7	30	16	.	.	.
cord-308212-l8flyso7	31	1	"	"	``
cord-308212-l8flyso7	31	2	Application	application	NN
cord-308212-l8flyso7	31	3	of	of	IN
cord-308212-l8flyso7	31	4	ethical	ethical	JJ
cord-308212-l8flyso7	31	5	principles	principle	NNS
cord-308212-l8flyso7	31	6	of	of	IN
cord-308212-l8flyso7	31	7	resource	resource	NN
cord-308212-l8flyso7	31	8	allocation	allocation	NN
cord-308212-l8flyso7	31	9	in	in	IN
cord-308212-l8flyso7	31	10	the	the	DT
cord-308212-l8flyso7	31	11	COVID-19	COVID-19	NNP
cord-308212-l8flyso7	31	12	pandemic	pandemic	NN
cord-308212-l8flyso7	31	13	"	"	''
cord-308212-l8flyso7	31	14	107	107	CD
cord-308212-l8flyso7	31	15	(	(	-LRB-
cord-308212-l8flyso7	31	16	adapted	adapt	VBN
cord-308212-l8flyso7	31	17	from	from	IN
cord-308212-l8flyso7	31	18	Emanuel	Emanuel	NNP
cord-308212-l8flyso7	31	19	et	et	NNP
cord-308212-l8flyso7	31	20	al	al	NNP
cord-308212-l8flyso7	31	21	.	.	.
cord-308212-l8flyso7	32	1	3	3	LS
cord-308212-l8flyso7	32	2	)	)	-RRB-
cord-308212-l8flyso7	32	3	108	108	CD
cord-308212-l8flyso7	33	1	Saving	save	VBG
cord-308212-l8flyso7	33	2	the	the	DT
cord-308212-l8flyso7	33	3	most	most	JJS
cord-308212-l8flyso7	33	4	lives	life	NNS
cord-308212-l8flyso7	33	5	/	/	SYM
cord-308212-l8flyso7	33	6	life	life	NN
cord-308212-l8flyso7	33	7	-	-	HYPH
cord-308212-l8flyso7	33	8	years	year	NNS
cord-308212-l8flyso7	33	9	is	be	VBZ
cord-308212-l8flyso7	33	10	the	the	DT
cord-308212-l8flyso7	33	11	highest	high	JJS
cord-308212-l8flyso7	33	12	priority	priority	NN
cord-308212-l8flyso7	33	13	.	.	.
cord-308212-l8flyso7	34	1	Random	random	JJ
cord-308212-l8flyso7	34	2	selection	selection	NN
cord-308212-l8flyso7	34	3	can	can	MD
cord-308212-l8flyso7	34	4	be	be	VB
cord-308212-l8flyso7	34	5	used	use	VBN
cord-308212-l8flyso7	34	6	for	for	IN
cord-308212-l8flyso7	34	7	selecting	select	VBG
cord-308212-l8flyso7	34	8	among	among	IN
cord-308212-l8flyso7	34	9	patients	patient	NNS
cord-308212-l8flyso7	34	10	with	with	IN
cord-308212-l8flyso7	34	11	comparable	comparable	JJ
cord-308212-l8flyso7	34	12	prognoses	prognosis	NNS
cord-308212-l8flyso7	34	13	.	.	.
cord-308212-l8flyso7	35	1	Healthcare	healthcare	NN
cord-308212-l8flyso7	35	2	workers	worker	NNS
cord-308212-l8flyso7	35	3	should	should	MD
cord-308212-l8flyso7	35	4	be	be	VB
cord-308212-l8flyso7	35	5	prioritized	prioritize	VBN
cord-308212-l8flyso7	35	6	.	.	.
cord-308212-l8flyso7	36	1	With	with	IN
cord-308212-l8flyso7	36	2	other	other	JJ
cord-308212-l8flyso7	36	3	factors	factor	NNS
cord-308212-l8flyso7	36	4	equal	equal	JJ
cord-308212-l8flyso7	36	5	,	,	,
cord-308212-l8flyso7	36	6	give	give	VBP
cord-308212-l8flyso7	36	7	priority	priority	NN
cord-308212-l8flyso7	36	8	to	to	IN
cord-308212-l8flyso7	36	9	COVID-19	covid-19	JJ
cord-308212-l8flyso7	36	10	research	research	NN
cord-308212-l8flyso7	36	11	participants	participant	NNS
cord-308212-l8flyso7	36	12	.	.	.
cord-308212-l8flyso7	37	1	aligns	align	VBZ
cord-308212-l8flyso7	37	2	with	with	IN
cord-308212-l8flyso7	37	3	maximizing	maximize	VBG
cord-308212-l8flyso7	37	4	benefits	benefit	NNS
cord-308212-l8flyso7	37	5	e.g.	e.g.	RB
cord-308212-l8flyso7	37	6	saving	save	VBG
cord-308212-l8flyso7	37	7	most	most	JJS
cord-308212-l8flyso7	37	8	years	year	NNS
cord-308212-l8flyso7	37	9	of	of	IN
cord-308212-l8flyso7	37	10	life	life	NN
cord-308212-l8flyso7	37	11	or	or	CC
cord-308212-l8flyso7	37	12	preventing	prevent	VBG
cord-308212-l8flyso7	37	13	further	further	JJ
cord-308212-l8flyso7	37	14	spread	spread	NN
cord-308212-l8flyso7	37	15	of	of	IN
cord-308212-l8flyso7	37	16	virus	virus	NN
cord-308212-l8flyso7	37	17	.	.	.
cord-308212-l8flyso7	38	1	109	109	CD
cord-308212-l8flyso7	38	2	Hydroxychloroquine	Hydroxychloroquine	NNP
cord-308212-l8flyso7	38	3	and	and	CC
cord-308212-l8flyso7	38	4	azithromycin	azithromycin	NNP
cord-308212-l8flyso7	38	5	as	as	IN
cord-308212-l8flyso7	38	6	a	a	DT
cord-308212-l8flyso7	38	7	86	86	CD
cord-308212-l8flyso7	38	8	treatment	treatment	NN
cord-308212-l8flyso7	38	9	of	of	IN
cord-308212-l8flyso7	38	10	COVID-19	covid-19	NN
cord-308212-l8flyso7	38	11	:	:	:
cord-308212-l8flyso7	38	12	results	result	NNS
cord-308212-l8flyso7	38	13	of	of	IN
cord-308212-l8flyso7	38	14	an	an	DT
cord-308212-l8flyso7	38	15	open	open	JJ
cord-308212-l8flyso7	38	16	-	-	HYPH
cord-308212-l8flyso7	38	17	label	label	NN
cord-308212-l8flyso7	38	18	non	non	JJ
cord-308212-l8flyso7	38	19	-	-	JJ
cord-308212-l8flyso7	38	20	randomized	randomized	JJ
cord-308212-l8flyso7	38	21	clinical	clinical	JJ
cord-308212-l8flyso7	38	22	trial	trial	NN
cord-308212-l8flyso7	38	23	Potential	Potential	NNP
cord-308212-l8flyso7	38	24	Shortages	Shortages	NNPS
cord-308212-l8flyso7	38	25	of	of	IN
cord-308212-l8flyso7	38	26	Hydroxychloroquine	Hydroxychloroquine	NNP
cord-308212-l8flyso7	38	27	for	for	IN
cord-308212-l8flyso7	38	28	Patients	patient	NNS
cord-308212-l8flyso7	38	29	89	89	CD
cord-308212-l8flyso7	38	30	with	with	IN
cord-308212-l8flyso7	38	31	Lupus	Lupus	NNP
cord-308212-l8flyso7	38	32	During	during	IN
cord-308212-l8flyso7	38	33	the	the	DT
cord-308212-l8flyso7	38	34	Coronavirus	Coronavirus	NNP
cord-308212-l8flyso7	38	35	Disease	Disease	NNP
cord-308212-l8flyso7	38	36	Fair	Fair	NNP
cord-308212-l8flyso7	38	37	Allocation	Allocation	NNP
cord-308212-l8flyso7	38	38	of	of	IN
cord-308212-l8flyso7	38	39	Scarce	Scarce	NNP
cord-308212-l8flyso7	38	40	Medical	Medical	NNP
cord-308212-l8flyso7	38	41	Resources	Resources	NNPS
cord-308212-l8flyso7	38	42	in	in	IN
cord-308212-l8flyso7	38	43	92	92	CD
cord-308212-l8flyso7	39	1	the	the	DT
cord-308212-l8flyso7	39	2	Time	Time	NNP
cord-308212-l8flyso7	39	3	of	of	IN
cord-308212-l8flyso7	39	4	Covid-19	Covid-19	NNP
cord-308212-l8flyso7	39	5	A	A	NNP
cord-308212-l8flyso7	39	6	randomized	randomized	JJ
cord-308212-l8flyso7	39	7	study	study	NN
cord-308212-l8flyso7	39	8	of	of	IN
cord-308212-l8flyso7	39	9	the	the	DT
cord-308212-l8flyso7	39	10	effect	effect	NN
cord-308212-l8flyso7	39	11	of	of	IN
cord-308212-l8flyso7	39	12	withdrawing	withdraw	VBG
cord-308212-l8flyso7	39	13	95	95	CD
cord-308212-l8flyso7	39	14	hydroxychloroquine	hydroxychloroquine	NN
cord-308212-l8flyso7	39	15	sulfate	sulfate	NN
cord-308212-l8flyso7	39	16	in	in	IN
cord-308212-l8flyso7	39	17	systemic	systemic	JJ
cord-308212-l8flyso7	39	18	lupus	lupus	NN
cord-308212-l8flyso7	39	19	erythematosus	erythematosus	NN
cord-308212-l8flyso7	39	20	Ethical	Ethical	NNP
cord-308212-l8flyso7	39	21	Framework	Framework	NNP
cord-308212-l8flyso7	39	22	for	for	IN
cord-308212-l8flyso7	39	23	Health	Health	NNP
cord-308212-l8flyso7	39	24	Care	Care	NNP
cord-308212-l8flyso7	39	25	Institutions	Institutions	NNPS
cord-308212-l8flyso7	39	26	&	&	CC
cord-308212-l8flyso7	39	27	Guidelines	Guidelines	NNPS
cord-308212-l8flyso7	39	28	for	for	IN
cord-308212-l8flyso7	39	29	Institutional	Institutional	NNP
cord-308212-l8flyso7	39	30	Ethics	Ethics	NNP
cord-308212-l8flyso7	39	31	98	98	CD
cord-308212-l8flyso7	39	32	Services	service	NNS
cord-308212-l8flyso7	39	33	Responding	respond	VBG
cord-308212-l8flyso7	39	34	to	to	IN
cord-308212-l8flyso7	39	35	the	the	DT
cord-308212-l8flyso7	39	36	Coronavirus	Coronavirus	NNP
cord-308212-l8flyso7	39	37	Pandemic	Pandemic	NNP
cord-308212-l8flyso7	39	38	-The	-The	NNP
cord-308212-l8flyso7	39	39	Hastings	Hastings	NNP
cord-308212-l8flyso7	39	40	Center	Center	NNP